Ependymoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Ependymomas | Ependymomas accounts for about 5% of adult intracranial [[gliomas]] and about 9% of childhood tumors of the central nervous system (CNS). | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 21:03, 21 August 2015
|
Ependymoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ependymoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Ependymoma epidemiology and demographics |
|
Risk calculators and risk factors for Ependymoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ependymomas accounts for about 5% of adult intracranial gliomas and about 9% of childhood tumors of the central nervous system (CNS).
Epidemiology and Demographics
Incidence
- Childhood Ependymoma represents about 200 cases per year in the United States[1].
Age
- Their occurrence seems to peak at age 5 years and then again at age 35.
- Subependymoma usually affects people over 40 years of age.
Gender
- Subependymoma more often affects men than women.
References
- ↑ National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq